Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1965 2
1966 1
1968 2
1969 17
1970 5
1971 1
1972 6
1973 2
1974 8
1975 10
1976 5
1977 5
1978 2
1979 2
1980 1
1981 6
1982 3
1983 6
1984 6
1985 5
1986 4
1987 1
1988 7
1989 2
1990 6
1991 1
1992 2
1993 5
1994 2
1995 3
1996 5
1997 6
1998 5
1999 9
2000 2
2001 8
2002 8
2003 6
2004 7
2005 9
2006 15
2007 22
2008 18
2009 19
2010 32
2011 30
2012 45
2013 51
2014 50
2015 36
2016 36
2017 47
2018 37
2019 32
2020 45
2021 60
2022 45
2023 17

Text availability

Article attribute

Article type

Publication date

Search Results

770 results

Results by year

Filters applied: . Clear all
Page 1
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
González-Martín A, Pothuri B, Vergote I, DePont Christensen R, Graybill W, Mirza MR, McCormick C, Lorusso D, Hoskins P, Freyer G, Baumann K, Jardon K, Redondo A, Moore RG, Vulsteke C, O'Cearbhaill RE, Lund B, Backes F, Barretina-Ginesta P, Haggerty AF, Rubio-Pérez MJ, Shahin MS, Mangili G, Bradley WH, Bruchim I, Sun K, Malinowska IA, Li Y, Gupta D, Monk BJ; PRIMA/ENGOT-OV26/GOG-3012 Investigators. González-Martín A, et al. Among authors: baumann k. N Engl J Med. 2019 Dec 19;381(25):2391-2402. doi: 10.1056/NEJMoa1910962. Epub 2019 Sep 28. N Engl J Med. 2019. PMID: 31562799 Clinical Trial.
Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial.
Pfisterer J, Shannon CM, Baumann K, Rau J, Harter P, Joly F, Sehouli J, Canzler U, Schmalfeldt B, Dean AP, Hein A, Zeimet AG, Hanker LC, Petit T, Marmé F, El-Balat A, Glasspool R, de Gregorio N, Mahner S, Meniawy TM, Park-Simon TW, Mouret-Reynier MA, Costan C, Meier W, Reinthaller A, Goh JC, L'Haridon T, Baron Hay S, Kommoss S, du Bois A, Kurtz JE; AGO-OVAR 2.21/ENGOT-ov 18 Investigators. Pfisterer J, et al. Among authors: baumann k. Lancet Oncol. 2020 May;21(5):699-709. doi: 10.1016/S1470-2045(20)30142-X. Epub 2020 Apr 16. Lancet Oncol. 2020. PMID: 32305099 Clinical Trial.
Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases.
Xiang X, Wind K, Wiedemann T, Blume T, Shi Y, Briel N, Beyer L, Biechele G, Eckenweber F, Zatcepin A, Lammich S, Ribicic S, Tahirovic S, Willem M, Deussing M, Palleis C, Rauchmann BS, Gildehaus FJ, Lindner S, Spitz C, Franzmeier N, Baumann K, Rominger A, Bartenstein P, Ziegler S, Drzezga A, Respondek G, Buerger K, Perneczky R, Levin J, Höglinger GU, Herms J, Haass C, Brendel M. Xiang X, et al. Among authors: baumann k. Sci Transl Med. 2021 Oct 13;13(615):eabe5640. doi: 10.1126/scitranslmed.abe5640. Epub 2021 Oct 13. Sci Transl Med. 2021. PMID: 34644146
The S1 protein of SARS-CoV-2 crosses the blood-brain barrier in mice.
Rhea EM, Logsdon AF, Hansen KM, Williams LM, Reed MJ, Baumann KK, Holden SJ, Raber J, Banks WA, Erickson MA. Rhea EM, et al. Among authors: baumann kk. Nat Neurosci. 2021 Mar;24(3):368-378. doi: 10.1038/s41593-020-00771-8. Epub 2020 Dec 16. Nat Neurosci. 2021. PMID: 33328624 Free PMC article.
Efficacy of niraparib by time of surgery and postoperative residual disease status: A post hoc analysis of patients in the PRIMA/ENGOT-OV26/GOG-3012 study.
O'Cearbhaill RE, Pérez-Fidalgo JA, Monk BJ, Tusquets I, McCormick C, Fuentes J, Moore RG, Vulsteke C, Shahin MS, Forget F, Bradley WH, Hietanen S, O'Malley DM, Dørum A, Slomovitz BM, Baumann K, Selle F, Calvert PM, Artioli G, Levy T, Kumar A, Malinowska IA, Li Y, Gupta D, González-Martín A. O'Cearbhaill RE, et al. Among authors: baumann k. Gynecol Oncol. 2022 Jul;166(1):36-43. doi: 10.1016/j.ygyno.2022.04.012. Epub 2022 May 9. Gynecol Oncol. 2022. PMID: 35550709 Free PMC article. Clinical Trial.
[Fatigue].
Baumann K, Krayenbühl P. Baumann K, et al. Praxis (Bern 1994). 2009 Apr 29;98(9):465-71. doi: 10.1024/1661-8157.98.9.465. Praxis (Bern 1994). 2009. PMID: 19404904 German. No abstract available.
Rejuvenating senolytics.
Baumann K. Baumann K. Nat Rev Mol Cell Biol. 2018 Sep;19(9):543. doi: 10.1038/s41580-018-0047-5. Nat Rev Mol Cell Biol. 2018. PMID: 30054558 No abstract available.
Not so CRISP(R).
Baumann K. Baumann K. Nat Rev Mol Cell Biol. 2018 Oct;19(10):619. doi: 10.1038/s41580-018-0056-4. Nat Rev Mol Cell Biol. 2018. PMID: 30135542 No abstract available.
Making more exosomes.
Baumann K. Baumann K. Nat Rev Mol Cell Biol. 2021 Apr;22(4):242. doi: 10.1038/s41580-021-00358-6. Nat Rev Mol Cell Biol. 2021. PMID: 33686231 No abstract available.
770 results